Zobrazeno 1 - 10
of 75
pro vyhledávání: '"John W Sweetenham"'
Publikováno v:
JMIR Cancer, Vol 7, Iss 3, p e30492 (2021)
BackgroundThe COVID-19 pandemic has created an urgent need to rapidly disseminate health information, especially to those with cancer, because they face higher morbidity and mortality rates. At the same time, the pandemic’s disproportionate impact
Externí odkaz:
https://doaj.org/article/da4c812577e248be9d70808d7beff08a
Autor:
Susmita Sharma, John W. Sweetenham
Publikováno v:
European Medical Journal Oncology, Vol 6, Iss 1, Pp 109-119 (2018)
The prognosis of mantle cell lymphoma (MCL) has improved rapidly over recent years with the evolution of new management strategies. The disease, once considered fatal, has now become more of a chronic illness, with recurrent relapses that can be mana
Externí odkaz:
https://doaj.org/article/ee2711c256654529843bc74a6f055e8a
Autor:
Akshat Maneesh Patel, Maishara Muquith, Heather Reves, Hetalkumari Patel, Jesse Jaso, Weina Chen, Toral Patel, Neil Desai, Robert Timmerman, Kiran Kumar, Radhika Kainthla, Aimaz Afrough, Larry D. Anderson Jr., Stephen Chung, Yazan F. Madanat, Gurbakhash Kaur, Ankit Kansagra, Prapti Patel, Madhuri Vusirikala, Robert H. Collins, John W. Sweetenham, Farrukh T Awan, Praveen Ramakrishnan Geethakumari
Publikováno v:
Transplantation and Cellular Therapy. 28:S417-S418
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::438a059caf795b1dd723e9798d4c5405
https://doi.org/10.1016/s2666-6367(22)00695-9
https://doi.org/10.1016/s2666-6367(22)00695-9
Autor:
Kristen L Fessele, Irene Kaganman, H. James Hamrick, John W. Sweetenham, Kerin B. Adelson, Amy P. Abernethy, Neal J. Meropol, Joshua Kraut, Vineeta Agarwala, Ray D. Page, Kathi Mooney, Martineau James Tyler
Publikováno v:
Journal of Oncology Practice. 15:220-223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864b2fe471d12a08026679c35b441aff
https://doi.org/10.1200/jop.18.00408
https://doi.org/10.1200/jop.18.00408
Autor:
Simon J. Craddock Lee, Danh Q. Nguyen, Arthur S. Hong, Hannah Fullington, John W. Sweetenham, D. Mark Courtney, Navid Sadeghi, Ethan A. Halm, John Cox
Publikováno v:
JCO Oncol Pract
PURPOSE: To determine whether emergency department (ED) visit history prior to cancer diagnosis is associated with ED visit volume after cancer diagnosis. METHODS: This was a retrospective cohort study of adults (≥ 18 years) with an incident cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32843c0aff68b73aaa95eda0c6c2788f
https://pubmed.ncbi.nlm.nih.gov/34038164
https://pubmed.ncbi.nlm.nih.gov/34038164
BACKGROUND The COVID-19 pandemic has created an urgent need to rapidly disseminate health information, especially to those with cancer, because they face higher morbidity and mortality rates. At the same time, the pandemic’s disproportionate impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e82eb52cfed50f36dbc559d90aa01da
https://doi.org/10.2196/preprints.30492
https://doi.org/10.2196/preprints.30492
Autor:
Simon J. Craddock Lee, Hannah Fullington, Ethan A. Halm, Arthur S. Hong, John W. Sweetenham, Hannah Chang, D. Mark Courtney
Publikováno v:
JCO Oncol Pract
PURPOSE: Patients with cancer undergoing treatment frequently visit the emergency department (ED) for commonly anticipated complaints (eg, pain, nausea, and vomiting). Nearly all Medicare Oncology Care Model (OCM) participants prioritized ED use redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8234d764e8f7cee5fba4564a3b57771
https://pubmed.ncbi.nlm.nih.gov/33417485
https://pubmed.ncbi.nlm.nih.gov/33417485
Autor:
Sandra Garcia, Ethan A Halm, Simon Craddock Lee, John W. Sweetenham, D. Mark Courtney, Arthur Hong
Publikováno v:
Journal of Clinical Oncology. 40:e18661-e18661
e18661 Background: The 30-day rate of readmission, a standard metric for many common acute medical conditions, has also been proposed as a quality measure in cancer. However, hospitalizations for cancer patients are more heterogeneous than traditiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b13a6a42545fc88ce4615cfb46f28470
https://doi.org/10.1200/jco.2022.40.16_suppl.e18661
https://doi.org/10.1200/jco.2022.40.16_suppl.e18661
Autor:
Anita D'Souza, John W. Sweetenham, Saurabh Dahiya, Ansh Mehta, Nathanael Fillmore, Ankit Kansagra
Publikováno v:
British Journal of Haematology. 191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505029bc961e58d12eb581aaab7497aa
https://doi.org/10.1111/bjh.17065
https://doi.org/10.1111/bjh.17065
Autor:
Andy I. Chen, Veronika Bachanova, Julie Lisano, Tamás Masszi, Jerzy Holowiecki, Auayporn Nademanee, Patrick J. Stiff, Craig H. Moskowitz, Simonetta Viviani, Connie Lee, Teresa McClendon, Muneer H. Abidi, Anna Sureda, Jan Walewski, John W. Sweetenham, Edward Agura
Publikováno v:
Blood. 132:2639-2642
The phase 3 AETHERA trial established brentuximab vedotin (BV) as a consolidative treatment option for adult patients with classical Hodgkin lymphoma (cHL) at high risk of relapse or progression after autologous hematopoietic stem-cell transplantatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da8e5f42986d82f25002aade3e02b86
https://doi.org/10.1182/blood-2018-07-861641
https://doi.org/10.1182/blood-2018-07-861641